Intervene is a pioneering company based in South San Francisco, CA, dedicated to providing an effective and widely-utilized therapy for patients suffering from Chronic Venous Insufficiency (CVI) caused by deep vein reflux (DVR). With an estimated 6.5 million Americans affected by DVR and moderate to severe CVI, Intervene aims to address the underlying problem of deep vein valve failure, offering a solution beyond the current palliative standard of care.
By developing a groundbreaking therapy, Intervene aims to alleviate the painful and costly symptoms of CVI, including leg swelling, pain, and open wounds (leg ulcers). With the current methods of treatment lacking in addressing the root cause of the condition, Intervene's innovative approach seeks to improve patients' quality of life and reduce the burden on the U.S. healthcare system caused by hospitalizations and wound care associated with CVI.
Generated from the website